Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Oct 7, 2022; 28(37): 5457-5468
Published online Oct 7, 2022. doi: 10.3748/wjg.v28.i37.5457
Table 1 The modified National Institute of Health risk classification of small Gastrointestinal stromal tumors
Risk classification
Tumor diameter (d/cm)
Mitotic count (number/50 HPF)
Very-lowD ≤ 2Mitotic ≤ 5
IntermediateD ≤ 25 < mitotic ≤ 10
HighD ≤ 2Mitotic > 10
Table 2 Clinicopathological characteristics of the patients
Characteristics
Cases (n = 256)
Age (year)57.4 ± 8.6
Sex, n (%)
Male69 (27.0)
Female187 (73.0)
Tumor location, n (%)
Cardia6 (2.3)
Fundus200 (78.1)
Body44 (17.2)
Antrum6 (2.4)
Endoscopic resection, n (%)
ESD136 (53.1)
EFTR120 (46.9)
Tumor size (cm), n (%)
≤ 1.48208 (81.3)
>1.4848 (18.7)
Mitotic index (/50HPF), n (%)
≤ 5248 (96.9)
> 58 (3.1)
Modified NIH classification, n (%)
Very-low232 (90.6)
Low16 (6.3)
Intermediate7 (2.7)
High1 (0.4)
Positive EUS features, n (%)
Heterogenous67 (65.1)
Hyperechoic foci22 (8.6)
Lobular border1 (0.4)
Ulceration2 (0.8)
Table 3 Comparisons of clinicopathological and endoscopic ultrasonographic features between ≤ 1.48 cm and > 1.48 cm groups
CharacteristicTumor size
≤ 1.48 cm group
> 1.48 cm group
P value
Age (year)57.3 ± 8.658.2 ± 8.40.49
Sex0.368
Men5910
Women14938
Tumor location0.01
Fundus16832
Body3410
Antrum42
Cardia24
Mitotic index (/50 HPFs)< 0.001
≤ 520741
>517
Positive EUS features10.002
Yes6525
No14323
Table 4 Comparisons of positive endoscopic ultrasonographic features between the pathologically non-low-risk group and low-risk group
Positive EUS featuresRisk classification
Intermediate/high
Very low/low
P value
Heterogeneous0.031
Yes562
No3186
Hyperechoic fociNS
Yes022
No8226
UlcersNS
Yes02
No8246